Compounds > chloroquine

chloroquine and pentobarbital

chloroquine has been researched along with pentobarbital in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (60.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (20.00)	29.6817
2010's	3 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Sen, S; Sinha, N	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ayitey-Smith, E	2
Bourn, WM; Chin, L; Laird, HE; Picchioni, AL	1
Ar'eva, EM; Iaroshevskiĭ, AIa	1
Chin, L; Duplisse, BR; Picchioni, AL	1
Dixon, PA; Oforah, E	1
Back, DJ; Breckenridge, AM; Orme, ML; Purba, HS; Staiger, C	1
Chin, L; Gillespie, T; Picchioni, AL	2

Reviews

1 review(s) available for chloroquine and pentobarbital

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

14 other study(ies) available for chloroquine and pentobarbital

Article	Year
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents. Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18 Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
Potentiation of pentobarbitone sleeping time by chloroquine in the rat [proceedings]. West African journal of pharmacology and drug research, 1976, Volume: 3, Issue:1 Topics: Animals; Chloroquine; Drug Synergism; Pentobarbital; Rats; Sleep; Time Factors	1976
Optimal antidotal dose of activated charcoal. Toxicology and applied pharmacology, 1973, Volume: 26, Issue:1 Topics: Animals; Antidotes; Charcoal; Chloroquine; Intestinal Absorption; Isoniazid; Male; Pentobarbital; Rats; Time Factors	1973
[Treatment of chronic glomerulonephritis and pyelonephritis]. Voenno-meditsinskii zhurnal, 1971, Volume: 3 Topics: Anti-Bacterial Agents; Benzimidazoles; Chloroquine; Chronic Disease; Diet Therapy; Glomerulonephritis; Glucocorticoids; Health Resorts; Humans; Hydrochlorothiazide; Immunosuppressive Agents; Parasympatholytics; Pentobarbital; Physical Therapy Modalities; Pyelonephritis; Reserpine; USSR	1971
The action of activated charcoal on poisons in the digestive tract. Toxicology and applied pharmacology, 1970, Volume: 16, Issue:3 Topics: Animals; Aspirin; Barbiturates; Charcoal; Chloroquine; Chlorpheniramine; Chlorpromazine; Digestive System; Dogs; Glutethimide; Intestinal Absorption; Liver; Male; Pentobarbital; Poisoning; Rats; Time Factors	1970
Effect of drug pretreatment on the metabolic oxidation of chlorpromazine in rat. Pharmacology, 1983, Volume: 27, Issue:3 Topics: Animals; Anthracenes; Chloroquine; Chlorpromazine; Ethanol; Female; Male; Metyrapone; Oxidation-Reduction; Pentobarbital; Premedication; Pyridines; Quinine; Rats; Rats, Inbred Strains; Safrole	1983
Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat. Biochemical pharmacology, 1983, Jan-15, Volume: 32, Issue:2 Topics: Aminopyrine N-Demethylase; Animals; Antipyrine; Chloroquine; Kinetics; Male; Paralysis; Pentobarbital; Pharmaceutical Preparations; Primaquine; Rats; Rats, Inbred Strains; Sleep; Time Factors; Zoxazolamine	1983
Evaluation of activated charcoal-sorbitol suspension as an antidote. Journal of toxicology. Clinical toxicology, 1982, Volume: 19, Issue:5 Topics: Animals; Antidotes; Aspirin; Charcoal; Chloroquine; Chlorpheniramine; Drug Combinations; Drug Evaluation, Preclinical; Liver; Male; Pentobarbital; Rats; Rats, Inbred Strains; Sorbitol	1982
Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments. Clinical toxicology, 1981, Volume: 18, Issue:7 Topics: Animals; Antidotes; Aspirin; Cathartics; Charcoal; Chloroquine; Chlorpheniramine; Female; Pentobarbital; Rats; Sodium; Sulfates	1981
Potentiation of pentobarbitone sleeping time by chloroquine in the rat. Archives internationales de pharmacodynamie et de therapie, 1980, Volume: 243, Issue:2 Topics: Animals; Chloroquine; Drug Synergism; Female; Male; Pentobarbital; Rats; Sleep; Time Factors	1980